Trials / Sponsors / Michael Boyiadzis
Michael Boyiadzis
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Phase 0- Pilot Study of Pembrolizumab on Immune Cells in Patient With Refractory Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia | EARLY_Phase 1 | 2017-10-17 |
| Completed | A Phase II Study of Pembrolizumab as Post-Remission Treatment of Patients ≥ 60 With AML Acute Myeloid Leukemia | Phase 2 | 2016-10-04 |